ArticleBMC rheumatology2026
Temporomandibular joint disorders in patients with systemic sclerosis: a cross-sectional study.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsSystemic sclerosis (SSc) is a connective tissue disease that can affect multiple organs, including the musculoskeletal system and the temporomandibular joint (TMJ). This study aimed to determine the frequency and clinical characteristics of temporomandibular disorders (TMD) among patients with SSc.
methodsIn this cross-sectional analytical study, 69 patients diagnosed with SSc were evaluated through structured clinical examination and some Diagnostic Criteria for Temporomandibular Disorders which was symptom-based and performed using the DC/TMD questionnaire as a screening tool. Patients’ disease duration, severity (assessed by Metsger severity score) and skin involvement (assessed by the modified Rodnan skin score) were also recorded.
resultsThe mean age of participants was 52.26 ± 10.76 years; 82.6% were female. The median disease duration and severity were 9 years (IQR: 3–13), years and 3(IQR: 2.0–6.0), respectively. Based on DC/TMD criteria, 63.8% of the patients met diagnostic criteria for TMD. No statistically significant associations were found between TMD presence and patients’ age, disease duration, or skin score (p > 0.05).
conclusionTMD is highly prevalent among patients with systemic sclerosis, affecting more than 60% of the studied cohort. These findings underscore the need for routine TMJ screening in SSc patients, as early recognition and intervention may mitigate the impact of orofacial dysfunction on quality of life. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.